Search company, investor...

Satellos Bioscience

satellos.com

Founded Year

2018

Stage

IPO | IPO

Total Raised

$1M

Date of IPO

10/6/2022

About Satellos Bioscience

Satellos Bioscience develops small molecule drugs that restore faulty muscle regeneration observed in degenerative disease and muscle wasting disorders. The company was founded in 2018 and is based in Toronto, Canada.

Headquarters Location

65 Front St East Suite 201

Toronto, Ontario, M5E 1B5,

Canada

647-660-1780

Missing: Satellos Bioscience's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Satellos Bioscience's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Satellos Bioscience News

Satellos Bioscience GAAP EPS of -$0.05

Nov 24, 2022

Satellos Bioscience  press release ( OTC:ICOTF ): Q3 GAAP EPS of -$0.05. Satellos had cash and cash equivalents of $3.13M as at September 30, 2022. Recommended For You Newest To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Satellos Bioscience Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Satellos Bioscience Rank

Satellos Bioscience Frequently Asked Questions (FAQ)

  • When was Satellos Bioscience founded?

    Satellos Bioscience was founded in 2018.

  • Where is Satellos Bioscience's headquarters?

    Satellos Bioscience's headquarters is located at 65 Front St East, Toronto.

  • What is Satellos Bioscience's latest funding round?

    Satellos Bioscience's latest funding round is IPO.

  • How much did Satellos Bioscience raise?

    Satellos Bioscience raised a total of $1M.

  • Who are the investors of Satellos Bioscience?

    Investors of Satellos Bioscience include Parent Project Muscular Dystrophy.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.